Liberal Democrat MEP Rebecca Taylor has launched a scathing attack on UKIP’s sexist and patronising approach to women, following comments made by UKIP MEP Paul Nuttall over Nick Clegg’s proposals to update the system of parental leave.
Nuttall, UKIP’s Deputy Leader, claimed that “new mums can hardly breast-feed – as everyone knows is best – if they’ve gone back to work after a fortnight leaving dad in charge.”
Currently fathers have less right to parental leave than mothers but under Clegg’s proposals, both parents would have the right to choose whether to share parental leave.
Rebecca Taylor commented: Continue reading
Figures released by the European Commission today show that since 2007 almost 70,000 young Brits have studied or undertaken work experience in another European country thanks to the EU Erasmus mobility programme.
Since the scheme was launched in 1987, more than three million students from across Europe have received EU grants designed to cover part of the additional costs of living, studying and working abroad for a limited period of time.
For the year 2011-2012, 13662 young Brits – more than ever before – took up the opportunity to go abroad to study or gain work experience in companies or other organisations with the help of the Erasmus programme. Of the 4568 students who took advantage of a work placement abroad, a majority gained experience in the education sector but manufacturing, professional and technical activities also proofed popular.
Liberal Democrat European youth spokesperson Rebecca Taylor commented:
“It is fantastic to see ever greater numbers of British students take up the opportunity to study or work in another EU country with the help of Erasmus funding. Continue reading
Liberal Democrat MEPs in the Environment Committee today backed an important piece of legislation which will set the bar for transparency in medical research for years to come. The vote at committee stage on the Clinical Trials Regulation saw key amendments relating to transparency of clinical trial data adopted. This will require detailed clinical trial data on medicines to be published once the medicine is authorised.
Lib Dem European health spokesperson Rebecca Taylor MEP commented after the vote:
“Doctors should have access to vital safety and efficacy information on the medicines they prescribe to patients. In the past, that has not been the case. Today is the start of a sea change in data transparency that will lead to important clinical trial data being made publicly available as never before.
While I believe that it is necessary to publish detailed data for authorised medicines, some flexibility should be allowed in relation to non-commercial (academic) clinical trials, in order to encourage research and innovation rather than create barriers.
MEPs will now enter negotiations with national governments before a final vote on the legislation in the autumn.
For more information have a look at Rebecca’s blog.